LRMR

Larimar Therapeutics (LRMR)

About Larimar Therapeutics (LRMR)

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Details

Daily high

$4.04

Daily low

$3.90

Price at open

$3.91

52 Week High

$5.37

52 Week Low

$1.61

Market cap

334.7M

Dividend yield

0.00%

Volume

551,105

Avg. volume

1.5M

P/E ratio

-2.03

Larimar Therapeutics News